About 360biolabs
360biolabs is a Healthcare company based in Melbourne (Australia) founded in 2015, and was acquired by BioAgilytix in August 2021. Contract virology and immunology services are provided by 360biolabs. Its chief executive, as recorded, is Alistair Draffan. 360biolabs offers products and services including Pharmacokinetics Assays, Pharmacodynamics Assays, Immunogenicity Assays, Biomarkers Assays, and Vaccines and Infectious Diseases Services. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Bioanalytical Services.
Company details
360biolabs was founded in 2015 in Melbourne, Australia, as a contract research organization focused on virology and immunology. Services for drug, vaccine, and diagnostic development are delivered through facilities designated BSL-2 and BSL-3, including quarantine labs. Assays are designed, optimized, and validated by the team. Work with eight virus types, such as Herpes, Hepatitis, Retro, Orthomyxo, and Paramyxo, is supported. IND-enabling and clinical development services are also handled.
- Headquarters Melbourne, Australia
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website 360biolabs.com
- Social LinkedIn
- Acquired by BioAgilytix (Aug 2021)
- Investors
- Acquired byBioAgilytix
(Aug 2021)
Products & Services of 360biolabs
360biolabs offers a comprehensive portfolio of products and services, including Pharmacokinetics Assays, Pharmacodynamics Assays, Immunogenicity Assays, Biomarkers Assays, and Vaccines and Infectious Diseases Services.
Services for measuring drug concentrations in clinical studies.
Assays evaluating drug effects on biological systems.
Testing for immune responses to therapeutic drugs.
Analysis of biomarkers in clinical research studies.
Services for virology and infectious disease testing.
Investors in 360biolabs
360biolabs has secured backing from 1 investor. Prominent investors backing the company include BioAgilytix.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Large-molecule bioanalysis is provided for biologics and biosimilars development. | 2008 | bioagilytix.com | Durham, United States |
Investor details for 360biolabs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of 360biolabs
1 people are tracked at 360biolabs (1 in leadership).
| Name | Role | Group |
|---|---|---|
Alistair Draffan | CEO & President | Leadership |
Complete people profiles for 360biolabs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of 360biolabs
2 dated milestones of 360biolabs across 6 years, from founding to its latest funding, stage changes and deals.
- Founded 360biolabs is founded.
- Exit Acquired by BioAgilytix.
Web traffic of 360biolabs
The website of 360biolabs (360biolabs.com) receives about 2.3K visits a month.
- Monthly visits2.3K
▼ 26.8% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about 360Biolabs
Complete news archive for 360biolabs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about 360biolabs
360biolabs was founded in 2015.
360biolabs is headquartered in Melbourne, Australia. It is registered at Melbourne, Victoria, Australia.
Alistair Draffan is the CEO of 360biolabs, as recorded in our data.
360biolabs was founded in 2015 in Melbourne, Australia, as a contract research organization focused on virology and immunology. Services for drug, vaccine, and diagnostic development are delivered through facilities designated BSL-2 and BSL-3, including quarantine labs. Assays are designed, optimized, and validated by the team. Work with eight virus types, such as Herpes, Hepatitis, Retro, Orthomyxo, and Paramyxo, is supported. IND-enabling and clinical development services are also handled.
360biolabs offers Pharmacokinetics Assays, Pharmacodynamics Assays, Immunogenicity Assays, Biomarkers Assays, and Vaccines and Infectious Diseases Services.
360biolabs has 1 investor. Key investors include BioAgilytix.
Yes. 360biolabs was acquired by BioAgilytix in August 2021.

